UPDATE: Stifel Nicolaus Upgrades WebMD Health Corp to Buy Following Q4 Beat
Stifel Nicolaus upgraded WebMD Health Corp (NASDAQ: WBMD) from Hold to Buy and announced a $26.00 price target.
Stifel Nicolaus commented, "We are upgrading shares of WebMD to Buy from Hold and establishing a $26 12-month price target, which is approximately 12.0x our 2014 adjusted EBITDA estimate of $90.2 million. We believe that pricing changes (greater choice and simplicity) implemented in 4Q12 suggest advertising trends are likely to improve. We expect traction in mobile to continue and provide a catalyst for a turnaround at WebMD."
WebMD Health Corp closed at $16.30 on Thursday.
Latest Ratings for WBMD
|Apr 2015||Goldman Sachs||Downgrades||Neutral||Sell|
|Jan 2015||SunTrust Robinson Humphrey||Maintains||Neutral|
|Nov 2014||SunTrust Robinson Humphrey||Downgrades||Buy||Neutral|
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.